- Zentek (ZEN) has commenced a 4-year, $1.6M research project
- The project is in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto and Ford Powertrain Engineering Research and Development Centre (PERDC)
- Prof. Sain is the Endowed Ford Motor Canada Chair in Sustainable Materials
- Prof. Yan is the Tier 1 Canada Research Chair in Sustainable Bioproducts
- Zentek is an IP development and commercialization company focused on next-gen healthcare solutions
- Zentek Ltd. (ZEN) is down 1.76 per cent, trading at C$2.23 per share at 1:50 pm ET
Zentek (ZEN) has commenced a 4-year, $1.6M research project.
The project is in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto and Ford Powertrain Engineering Research and Development Centre.
Funding for the project includes $1.2M from the Mitacs Accelerate program. Prof. Sain is the Endowed Ford Motor Canada Chair in Sustainable Materials. He is active in the field of light energy storage, including cell chemistry and renewable fuel battery development at PERDC. Prof. Yan is the Tier 1 Canada Research Chair in Sustainable Bioproducts.
Collaborating with the PERDC and testing at this facility is essential to demonstrate battery advances at a scale suitable for the automotive industry. The project seeks to test novel concepts of inventing multifunctional materials for use in automotive battery components. It includes an anode, cathode, electrolyte, and separator.
Zentek will work in tandem with the University of Toronto researchers. It will provide and test advanced graphene materials, including Zentek’s patent-pending anode material developed by Dr. Michael Pope.
Since April, Dr. Pope’s team has optimized the anode material, which now has a specific capacity of over 1,000 mAh/g. It retains over 80 per cent of its capacity over 320 charge-discharge cycles. The specific capacity of this material is a significant improvement over common graphite anodes. However, the cycle life still requires improvement compared to typical electric vehicle batteries.
Zentek and Dr. Pope’s team will continue to develop this technology with the goal of improving performance to meet industry requirements.
Zentek is an IP development and commercialization company focused on next-gen healthcare solutions.
Zentek Ltd. (ZEN) is down 1.76 per cent, trading at C$2.23 per share at 1:50 pm ET.
